H.CON.RES.342 - Federal Government - Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

Please upgrade your Flash Player Home > Federal Government > H.CON.RES.342 Latest Update: Friday, July, 04th 2008 Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. 5/6/2008--Introduced. Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians. Comment on Bill - Be the first to leave a comment! Latest Actions 05/07/2008 - Referred to the Subcommittee on Health. 05/06/2008 - Referred to the House Committee on Energy and Commerce. Bill Text File name Last Updated H.CON.RES.342 Introduced in House 05/09/2008

Important People Sponsor Mike Ross Co-Sponsor(s) Anna G. Eshoo Ben Chandler Charles A. Gonzalez Christopher Shays Cliff Stearns Dan Boren Dan Burton Ed Pastor Gabrielle Giffords Ginny Brown-Waite Harry E. Mitchell Jeff Miller Jerry Weller Jim Cooper Jo Ann Emerson John Boozman John R. "Randy", Jr. Kuhl John R. Carter Kay Granger Louie Gohmert Mac Thornberry Marilyn N. Musgrave Marion Berry Michael C. Burgess Michael F. Doyle Michael H. Michaud Michael T. McCaul Nancy E. Boyda Ralph M. Hall Raul M. Grijalva Ray LaHood Rob Bishop Robert Wexler Ron Paul Sam Farr Spencer Bachus Tammy Baldwin Thomas H. Allen Tim Murphy Trent Franks Vic Snyder Virgil H., Jr. Goode Zach Wamp Zoe Lofgren Latest News Searching for articles... You can suggest an article. Paste URL. Articles are subject to approval.